Dual CDK 4/6 inhibitor demonstrates potent antitumor efficacy in vitro and in vivo against esophageal adenocarcinoma
Publication
, Conference
Omstead, AN; Kosovec, JE; Biedka, MJ; Biederman, RWW; Kelly, RJ; Zaidi, AH; Jobe, BA
Published in: ANNALS OF ONCOLOGY
2017
Duke Scholars
Published In
ANNALS OF ONCOLOGY
EISSN
1569-8041
ISSN
0923-7534
Publication Date
2017
Volume
28
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Omstead, A. N., Kosovec, J. E., Biedka, M. J., Biederman, R. W. W., Kelly, R. J., Zaidi, A. H., & Jobe, B. A. (2017). Dual CDK 4/6 inhibitor demonstrates potent antitumor efficacy in vitro and in vivo against esophageal adenocarcinoma. In ANNALS OF ONCOLOGY (Vol. 28).
Omstead, A. N., J. E. Kosovec, M. J. Biedka, R. W. W. Biederman, R. J. Kelly, A. H. Zaidi, and B. A. Jobe. “Dual CDK 4/6 inhibitor demonstrates potent antitumor efficacy in vitro and in vivo against esophageal adenocarcinoma.” In ANNALS OF ONCOLOGY, Vol. 28, 2017.
Omstead AN, Kosovec JE, Biedka MJ, Biederman RWW, Kelly RJ, Zaidi AH, et al. Dual CDK 4/6 inhibitor demonstrates potent antitumor efficacy in vitro and in vivo against esophageal adenocarcinoma. In: ANNALS OF ONCOLOGY. 2017.
Omstead, A. N., et al. “Dual CDK 4/6 inhibitor demonstrates potent antitumor efficacy in vitro and in vivo against esophageal adenocarcinoma.” ANNALS OF ONCOLOGY, vol. 28, 2017.
Omstead AN, Kosovec JE, Biedka MJ, Biederman RWW, Kelly RJ, Zaidi AH, Jobe BA. Dual CDK 4/6 inhibitor demonstrates potent antitumor efficacy in vitro and in vivo against esophageal adenocarcinoma. ANNALS OF ONCOLOGY. 2017.
Published In
ANNALS OF ONCOLOGY
EISSN
1569-8041
ISSN
0923-7534
Publication Date
2017
Volume
28
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3202 Clinical sciences
- 1112 Oncology and Carcinogenesis